[REVISION HISTORY]

South Korea telemedicine and pharmaceutical delivery debate

Updated 9 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-21 02:25 UTC → 2026-10-27 06:17 UTC · added ~~removed~~

South Korea is experiencing significant tension regarding telemedicine regulations and the expansion of pharmaceutical delivery services. The National Assembly passed an amendment to the Pharmaceutical Affairs Act, known as the ‘Doctor Now Prevention Act’, which prohibits telemedicine platforms from acting as pharmaceutical wholesalers to prevent conflicts of interest and illegal rebates. While the pharmaceutical industry welcomed this, the venture and startup sectors argue the law stifles innovation by banning entire business models. The government has proposed expanding medicine delivery to all telemedicine patients, moving beyond current restrictions for vulnerable groups. The Korean Pharmaceutical Association (KPA) has ~~declared a boycott of government discussions, arguing~~ launched large-scale protests against this, with over 10,000 members rallying in Gwanghwamun. The KPA argues that ~~expanding delivery before establishing secure systems for medication guidance undermines existing laws.~~ expansion without sufficient safety measures could lead to drug misuse, medicine degradation, and compromised medical data. To intensify opposition, the KPA ~~President Kwon Young-hee criticized~~ has maintained an emergency response committee to fight against drug delivery expansion and the ~~government’s focus as “desk administration,” urging instead for a public healthcare safety net, such as mandated public late-night pharmacies.~~ expansion of over-the-counter medicine categories. Medical professionals have also intensified calls to halt ~~expansions due to safety concerns.~~ expansions. The Korean Medical Association of Private Practitioners (KMAP) warned that prioritizing convenience over physical examinations could lead to misdiagnosis of acute ~~conditions. KMAP also noted~~ conditions, noting over 10,000 cases of potential drug abuse involving narcotics during pilot programs. ~~Recently,~~ Specialist groups, including otolaryngologists, ophthalmologists, and dermatologists, have joined the ~~Ministry of Health~~ opposition, arguing that specialized equipment and ~~Welfare announced proposed amendments to~~ physical examinations of texture or depth cannot be replaced by video or photos. As the ~~Medical Service Act to expand~~ government moves toward final negotiations scheduled for December 24, key contentions remain regarding the ~~scope~~ proposed expansion of first-visit ~~telemedicine, allowing remote consultations from clinics within the same city or province. While the proposal prohibits prescribing narcotics~~ telemedicine and ~~obesity treatments, it allows for one-time~~ the controversial provision allowing up to 30-day prescriptions for initial visits if deemed necessary by a professional. The Korean Medical Association (KMA) has strongly opposed this, warning that longer prescription periods and first-visit remote access increase risks of misdiagnosis and drug abuse. Adding to these tensions, the Korean Internal Medicine Association has urged the government to suspend the telemedicine pilot program ahead of its scheduled full-scale launch in December.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.